BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 21539837)

  • 1. Pemirolast reduces cisplatin-induced kaolin intake in rats.
    Tatsushima Y; Egashira N; Matsushita N; Kurobe K; Kawashiri T; Yano T; Oishi R
    Eur J Pharmacol; 2011 Jul; 661(1-3):57-62. PubMed ID: 21539837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of dexamethasone, ondansetron and a tachykinin NK1 receptor antagonist (GR205171) on cisplatin-induced changes in behaviour, food intake, pica and gastric function in rats.
    Malik NM; Liu YL; Cole N; Sanger GJ; Andrews PL
    Eur J Pharmacol; 2007 Jan; 555(2-3):164-73. PubMed ID: 17141213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of cisplatin-induced acute and delayed emesis by the selective neurokinin-1 antagonists, L-758,298 and MK-869.
    Van Belle S; Lichinitser MR; Navari RM; Garin AM; Decramer ML; Riviere A; Thant M; Brestan E; Bui B; Eldridge K; De Smet M; Michiels N; Reinhardt RR; Carides AD; Evans JK; Gertz BJ
    Cancer; 2002 Jun; 94(11):3032-41. PubMed ID: 12115394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The oral NK(1) antagonist, aprepitant, given with standard antiemetics provides protection against nausea and vomiting over multiple cycles of cisplatin-based chemotherapy: a combined analysis of two randomised, placebo-controlled phase III clinical trials.
    de Wit R; Herrstedt J; Rapoport B; Carides AD; Guoguang-Ma J; Elmer M; Schmidt C; Evans JK; Horgan KJ
    Eur J Cancer; 2004 Feb; 40(3):403-10. PubMed ID: 14746859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The oral NK(1) antagonist aprepitant for the prevention of acute and delayed chemotherapy-induced nausea and vomiting: Pooled data from 2 randomised, double-blind, placebo controlled trials.
    Warr DG; Grunberg SM; Gralla RJ; Hesketh PJ; Roila F; Wit Rd; Carides AD; Taylor A; Evans JK; Horgan KJ
    Eur J Cancer; 2005 Jun; 41(9):1278-85. PubMed ID: 15939263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tranexamic acid induces kaolin intake stimulating a pathway involving tachykinin neurokinin 1 receptors in rats.
    Kakiuchi H; Kawarai-Shimamura A; Kuwagata M; Orito K
    Eur J Pharmacol; 2014 Jan; 723():1-6. PubMed ID: 24333477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pemirolast potently attenuates paclitaxel hypersensitivity reactions through inhibition of the release of sensory neuropeptides in rats.
    Itoh Y; Sendo T; Hirakawa T; Takasaki S; Goromaru T; Nakano H; Oishi R
    Neuropharmacology; 2004 May; 46(6):888-94. PubMed ID: 15033348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishing the dose of the oral NK1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting.
    Chawla SP; Grunberg SM; Gralla RJ; Hesketh PJ; Rittenberg C; Elmer ME; Schmidt C; Taylor A; Carides AD; Evans JK; Horgan KJ
    Cancer; 2003 May; 97(9):2290-300. PubMed ID: 12712486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiemetic effect of ondansetron and dexamethasone in gynecologic malignant patients receiving chemotherapy.
    Pradermdee P; Manusirivithaya S; Tangjitgamol S; Thavaramara T; Sukwattana P
    J Med Assoc Thai; 2006 Oct; 89 Suppl 4():S29-36. PubMed ID: 17725140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropharmacological mechanisms of emesis. II. Effects of antiemetic drugs on cisplatin-induced pica in rats.
    Takeda N; Hasegawa S; Morita M; Horii A; Uno A; Yamatodani A; Matsunaga T
    Methods Find Exp Clin Pharmacol; 1995 Dec; 17(10):647-52. PubMed ID: 9053584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of cisplatin-induced emesis by a selective neurokinin-1-receptor antagonist. L-754,030 Antiemetic Trials Group.
    Navari RM; Reinhardt RR; Gralla RJ; Kris MG; Hesketh PJ; Khojasteh A; Kindler H; Grote TH; Pendergrass K; Grunberg SM; Carides AD; Gertz BJ
    N Engl J Med; 1999 Jan; 340(3):190-5. PubMed ID: 9917226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pica--a model of nausea? Species differences in response to cisplatin.
    Liu YL; Malik N; Sanger GJ; Friedman MI; Andrews PL
    Physiol Behav; 2005 Jun; 85(3):271-7. PubMed ID: 15939445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of concurrent use of ondansetron hydrochloride and dexamethasone against nausea and vomiting in lung cancer patients receiving cisplatin].
    Tanimura S; Banba J; Tomoyasu H; Masaki M
    Gan To Kagaku Ryoho; 1998 Dec; 25(14):2275-81. PubMed ID: 9881085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Addition of the neurokinin 1 receptor antagonist aprepitant to standard antiemetic therapy improves control of chemotherapy-induced nausea and vomiting. Results from a randomized, double-blind, placebo-controlled trial in Latin America.
    Poli-Bigelli S; Rodrigues-Pereira J; Carides AD; Julie Ma G; Eldridge K; Hipple A; Evans JK; Horgan KJ; Lawson F;
    Cancer; 2003 Jun; 97(12):3090-8. PubMed ID: 12784346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Action of (R)-sila-venlafaxine and reboxetine to antagonize cisplatin-induced acute and delayed emesis in the ferret.
    Warneck JB; Cheng FH; Barnes MJ; Mills JS; Montana JG; Naylor RJ; Ngan MP; Wai MK; Daiss JO; Tacke R; Rudd JA
    Toxicol Appl Pharmacol; 2008 Nov; 232(3):369-75. PubMed ID: 18675289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiemetic role of thalidomide in a rat model of cisplatin-induced emesis.
    Han ZX; Xu J; Wang HM; Ma J; Sun X; Du XP
    Cell Biochem Biophys; 2014 Sep; 70(1):361-5. PubMed ID: 24718779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of granisetron, a 5-HT3 receptor antagonist, on 5-hydroxytryptamine (5-HT) release from the isolated ileum in a delayed-emesis rat model.
    Endo T; Hamaue N; Ihira E; Teramoto Y; Liu Y; Hirafuji M; Minami M
    Res Commun Mol Pathol Pharmacol; 2002; 111(1-4):55-68. PubMed ID: 14632314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. American ginseng berry extract and ginsenoside Re attenuate cisplatin-induced kaolin intake in rats.
    Mehendale S; Aung H; Wang A; Yin JJ; Wang CZ; Xie JT; Yuan CS
    Cancer Chemother Pharmacol; 2005 Jul; 56(1):63-9. PubMed ID: 15791456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered feeding behaviour induced by long-term cisplatin in rats.
    Vera G; Chiarlone A; Martín MI; Abalo R
    Auton Neurosci; 2006 Jun; 126-127():81-92. PubMed ID: 16567130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electroacupuncture alleviates cisplatin-induced nausea in rats.
    Cui Y; Wang L; Shi G; Liu L; Pei P; Guo J
    Acupunct Med; 2016 Apr; 34(2):120-6. PubMed ID: 26386034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.